Industry Analysis & Industry Trends
The Australian biotechnology industry is one of the largest in the world. Biotechnology is an increasingly important part of product development in a variety of industries. Biotechnology refers to the use of living organisms, or their products, to modify human health and the environment. While genetically modified products remain controversial, attitudes are beginning to change and there has been increasing acceptance of the process in agricultural industries and across other sectors.
Biotechnology companies often use research that began in higher education, public and not-for-profit research organisations. While company stock sales and interest income fund a large amount of biotech R&D, funding largely comes from government and non-profit organisations... purchase to read more
Industry Report - Industry Key Buyers Chapter
Biotech companies tend to be small enterprises with one to a few compounds in development. Many of these companies operate at a loss due to the length and cost of R&D processes. The industry therefore tends to be highly fragmented.
Australia's Biotechnology industry has a low level of market share concentration, with the top four players accounting for less than 20% of the market. Industry firms include heavyweight CSL (which offers a range of commercialised products and generates billions in global sales revenue), foreign subsidiary pharmaceutical and agricultural companies (such as Amgen and Monsanto) and many small operations that are yet to commercialise any products and survive on research grants... purchase to read more